Primary care opioid use disorders treatment trial (CTN-0074). 9/1/2020 - 12/31/2021. N01DA-19-2250. Task order 75N95020F00004 (TO15).
Ended Awarded Last action
- Contract number
- 75N95020F00004
- Awardee
-
The Emmes Company, LLC UEI NBQCBJ6FXBU4
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $215,776
Award facts
- Opportunity
-
- 75N95020F00004 Solicitation number
- Contract value 100% obligated
- $215,775.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$20,595 | |
| Change Order | $0 | |
| Original award | $236,371 |
About this award
This federal contract award, with an ID of 75N95019D00013|75N95020F00004, was issued by the National Institute on Drug Abuse (NIDA) to The Emmes Company LLC, a global clinical research organization based in Rockville, Maryland. The contract supports the PRIMARY CARE OPIOID USE DISORDERS TREATMENT TRIAL (CTN-0074) from 9/1/2020 to 12/31/2021, with a potential completion date of 8/31/2022. The contract is a Delivery Order valued at $215,775.68 with a Cost Plus Fixed Fee pricing type. The Emmes Company LLC, a for-profit limited liability company, has been awarded multiple federal contracts and grants from NIDA and other NIH institutes to provide comprehensive research support services, including clinical trial coordination, data management, and regulatory support. This contract does not have a set-aside designation.
Quick answers
Who was awarded contract 75N95020F00004?
75N95020F00004 was awarded to The Emmes Company, LLC by National Institute on Drug Abuse (National Institutes of Health) on September 1, 2020.
How much is contract 75N95020F00004 worth?
The government has obligated $215,776 on 75N95020F00004.
Is contract 75N95020F00004 an order under another contract?
Yes. 75N95020F00004 is a delivery order under 75N95019D00013, an indefinite delivery contract.
Was contract 75N95020F00004 competed?
The extent of competition for 75N95020F00004 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award